NURE
Price
$31.73Alerts
Change
-$0.50 (-1.55%)
Updated
Nov 19, 03:56 PM (EDT)
Net Assets
32.41M
Intraday BUY SELL Signals
VNQ
Price
$93.48Alerts
Change
-$1.69 (-1.78%)
Updated
Nov 19, 04:59 PM (EDT)
Net Assets
39.18B
Intraday BUY SELL Signals
Interact to see
Advertisement

NURE vs VNQ

NURE vs VNQ Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
Nov 05, 2026

Which ETF would AI Choose? Nuveen Short-Term REIT ETF (NURE) vs. Vanguard Real Estate ETF (VNQ)

Key Takeaways

  • NURE is a narrow, thematic fund of roughly 30 short-lease real estate investment trusts (REITs — companies that own and operate income-producing property), while VNQ offers broad exposure across about 150 U.S. real estate securities.
  • Cost efficiency strongly favors VNQ, whose 0.13% expense ratio is less than half of NURE's 0.36%.
  • Diversification and liquidity also favor VNQ, which spans healthcare, retail, telecom tower, industrial, and data-center REITs versus NURE's concentrated focus on apartments, hotels, self-storage, and single-family rentals.
  • NURE's short-lease tilt can offer relative resilience in shifting rate environments, but its small asset base introduces structural and liquidity trade-offs.
  • Tickeron AI Verdict: VNQ — its broader exposure, lower cost, deeper liquidity, and more consistent structural profile make it the favored choice between the two.

Introduction

Both NURE and VNQ operate in the same broad real-estate sector, but they answer very different investor questions. VNQ is a diversified core building block, while NURE is a tactical thematic instrument. This ETF comparison matters right now because interest-rate expectations, sector rotation, and the divergent fortunes of short-lease versus long-lease property owners are reshaping relative positioning across the real-estate market. Comparing the two funds' sector exposure, fund performance, and structural traits helps investors decide whether broad coverage or a targeted short-lease strategy better suits their goals.

Nuveen Short-Term REIT ETF (NURE) Overview

NURE is a passively managed fund that tracks the Dow Jones U.S. Select Short-Term REIT Index, a subset of the broader Dow Jones U.S. Select REIT Index. The strategy targets equity REITs that typically hold assets with shorter-than-average lease durations — chiefly apartments, hotels, self-storage facilities, manufactured housing, and single-family rentals. Because these leases reset frequently, the underlying rents can reprice more quickly with inflation and economic conditions than long-lease office or industrial contracts.

The fund holds approximately 30 securities, making it relatively concentrated. Its top holdings include Host Hotels & Resorts (HST), Ryman Hospitality Properties (RHP), Invitation Homes (INVH), American Homes 4 Rent (AMH), Essex Property Trust (ESS), Equity Residential (EQR), Camden Property Trust (CPT), Public Storage (PSA), and CubeSmart (CUBE). NURE carries a 0.36% expense ratio and, as a non-diversified fund with a modest asset base, tends to offer thinner trading liquidity than larger real-estate peers.

Vanguard Real Estate ETF (VNQ) Overview

VNQ is one of the largest and longest-tenured real-estate funds in the market, tracking the MSCI US Investable Market Real Estate 25/50 Index. Launched in 2004, it provides broad, market-capitalization-weighted exposure across the full U.S. listed real-estate landscape, including equity REITs and selected real-estate operating companies.

With roughly 150 holdings, VNQ is far more diversified than NURE. Its largest positions include Welltower (WELL), Prologis (PLD), Equinix (EQIX), American Tower (AMT), Simon Property Group (SPG), Digital Realty Trust (DLR), Realty Income (O), Public Storage (PSA), and AvalonBay Communities (AVB). Its sector mix spans healthcare, retail, telecom tower, industrial, data-center, and residential REITs. The fund's 0.13% expense ratio and substantial assets under management (AUM — the total market value of assets the fund manages) support tight spreads and deep liquidity.

Industry and Thematic Backdrop

Both funds sit at the intersection of real-estate fundamentals and interest-rate policy. Because REITs rely heavily on borrowed capital and are valued partly on their dividend yields, higher-for-longer rate expectations have pressured the sector in recent market cycles. Within that environment, short-lease property types — hotels, apartments, and self-storage — have benefited from the ability to reprice rents rapidly, while long-duration and capital-intensive segments such as data centers, towers, and healthcare have been driven more by secular technology and demographic demand.

Capital flows have increasingly favored specialized and growth-oriented real estate, including data centers tied to artificial intelligence demand and senior-housing assets linked to an aging population. These catalysts favor VNQ's broad, modern-sector exposure, while NURE's concentration in lodging and residential segments leaves it more sensitive to consumer spending and housing-market cycles.

Performance and Positioning Comparison

In recent weeks and across recent market cycles, the two funds have exhibited meaningfully different return profiles despite sharing a sector label. VNQ's weighting toward technology-adjacent real estate — data centers and telecom towers — has provided a tailwind tied to digital infrastructure spending, while its healthcare and retail holdings offer more defensive income streams. NURE's performance, by contrast, has been more closely correlated with travel demand, housing affordability, and short-term consumer sentiment.

From a relative positioning standpoint, VNQ typically carries lower single-security concentration risk and broader diversification, while NURE's focused portfolio can amplify volatility when the lodging or residential subsectors rotate. This concentration is a defining difference in fund performance dynamics and should factor into any investor's risk assessment.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending names, and breakout candidates more efficiently than manual screening. Explore the AI Screener to refine your own sector and ETF comparisons.

Tickeron AI Verdict

Based on observable structural factors, Tickeron's AI would likely favor VNQ between these two funds. VNQ's materially lower expense ratio, far broader diversification, deeper liquidity, and exposure to higher-momentum real-estate subsectors such as data centers and telecom towers give it a stronger risk-adjusted profile. While NURE's short-lease strategy offers a legitimate tactical angle, its concentration, higher cost, and smaller asset base present relative drawbacks. This assessment reflects probabilistic reasoning about structural strength and trend consistency rather than personalized investment advice.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
NURE vs. VNQ commentary
Nov 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NURE is a Hold and VNQ is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NURE with price predictions
Nov 18, 2026

NURE in upward trend: 10-day moving average moved above 50-day moving average on October 22, 2026

The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Bearish Trend Analysis

The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
a Summary for VNQ with price predictions
Nov 18, 2026

VNQ sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for VNQ moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for VNQ moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 23 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VNQ as a result. In 70 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

The Moving Average Convergence Divergence Histogram (MACD) for VNQ turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 37 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

VNQ broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

VNQ moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VNQ crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Following a +1.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where VNQ advanced for three days, in 253 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

The Aroon Indicator entered an Uptrend today. In 228 of 292 cases where VNQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

TECHNICAL ANALYSIS
Technical Analysis
NUREVNQ
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement

NURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURE
1D Price
Change %
NURE100%
+0.03%
UDR - NURE
83%
Closely correlated
+0.03%
MAA - NURE
82%
Closely correlated
-0.68%
CPT - NURE
80%
Closely correlated
-0.32%
ESS - NURE
76%
Closely correlated
+1.06%
VMRK - NURE
75%
Closely correlated
-0.78%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHFAN9.43-0.16
-1.67%
Brighthouse Financial
HOWL1.03-0.02
-1.90%
Werewolf Therapeutics
INTR3.81-0.11
-2.81%
Inter & Co
PRMB22.96-1.29
-5.32%
Primo Brands Corp.
ALLO0.70-0.05
-6.48%
Allogene Therapeutics